NRF1 and cancer: To obtain a clue to overcoming the resistance to proteasome inhibitors acquired by cancer cells, we explored the possible existence of a new putative pathway that controls the magnitude or threshold of the proteasome bounce-back response by investigating NRF1-interacting proteins in the nucleus, hoping to clarify a post-ER regulation of NRF1 activity.